IE
SGNT

Israel Englander’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Israel Englander’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-327,021
Closed -$3.98M – 3891
2016
Q1 		$3.98M Sell
327,021
-376,515
-54% -$5.28M 0.01% 1381
2015
Q4 		$11.2M Buy
703,536
+108,045
+18% +$1.7M 0.02% 869
2015
Q3 		$9.13M Buy
595,491
+287,210
+93% +$6.21M 0.02% 983
2015
Q2 		$7.49M Sell
308,281
-17,888
-5% -$429K 0.01% 1152
2015
Q1 		$7.58M Sell
326,169
-46,889
-13% -$1.24M 0.01% 1184
2014
Q4 		$9.37M Buy
373,058
+166,095
+80% +$4.87M 0.02% 1027
2014
Q3 		$6.44M Sell
206,963
-198,836
-49% -$5.39M 0.02% 1129
2014
Q2 		$10.5M Sell
405,799
-191,632
-32% -$4.26M 0.03% 799
2014
Q1 		$14M Buy
597,431
+247,295
+71% +$5.41M 0.04% 614
2013
Q4 		$8.89M Sell
350,136
-145,481
-29% -$3.29M 0.03% 791
2013
Q3 		$10.1M Buy
495,617
+321,548
+185% +$7.16M 0.03% 675
2013
Q2 		$3.65M Buy
+174,069
New +$3.11M 0.01% 1221

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $494M AUM 23.45% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Israel Englander's SGNT Position: Q2 2016 in Review

Israel Englander sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 327,021 shares — an estimated $3.98M sold.

Israel Englander first reported a position in SGNT in Q2 2013 and held it in 12 quarters. The position peaked at $14M in Q1 2014. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Israel Englander reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Israel Englander sold 327,021 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $3.98M.
  • Israel Englander first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Israel Englander's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $14M in Q1 2014.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Millennium Management's 13F filing for Q2 2016, filed 15 Aug 2016.